Grant: CIHR-ICRH Travel Awards - General pool
Research Institute of the McGill University Health Centre
$1,500.00
Plasma proteomic biomarkers of aortic stenosis: A Mendelian randomization study.
FY 2023-24
Summary
Aortic stenosis is a common heart disease affecting many elderly people, and the only treatment currently available is aortic valve replacement.By measuring plasma proteins and integrating them with genomic data, we can identify protein biomarkers that may contribute to the disease. Using a two-sample Mendelian randomization approach, we analyzed publicly available data from the Atherosclerosis Risk in Communities (ARIC) study and a meta-analysis of ten genome-wide association studies of aortic stenosis. We identified three genes, ITPA, ACE, and PCSK9, as potential therapeutic targets for the disease. Additionally, ACE and PCSK9 are already recognized as viable drug targets. Further research is needed to determine whether these drugs may be repurposed to treat aortic stenosis. In conclusion, this study is the largest of its kind to date and provides valuable insights into the genetic causes of the diseas
Department
Program
CIHR-ICRH Travel Awards - General pool
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
495590
Name
Yang Ta-Yu
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases
Projecttitle
Plasma proteomic biomarkers of aortic stenosis: A Mendelian randomization study.
Programtype2
Undefined
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
CIHR-ICRH Travel Awards - General pool
Keyworddelim
Aortic Stenosis
Abstract
Aortic stenosis is a common heart disease affecting many elderly people, and the only treatment currently available is aortic valve replacement.By measuring plasma proteins and integrating them with genomic data, we can identify protein biomarkers that may contribute to the disease. Using a two-sample Mendelian randomization approach, we analyzed publicly available data from the Atherosclerosis Risk in Communities (ARIC) study and a meta-analysis of ten genome-wide association studies of aortic stenosis. We identified three genes, ITPA, ACE, and PCSK9, as potential therapeutic targets for the disease. Additionally, ACE and PCSK9 are already recognized as viable drug targets. Further research is needed to determine whether these drugs may be repurposed to treat aortic stenosis. In conclusion, this study is the largest of its kind to date and provides valuable insights into the genetic causes of the diseas
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yang, Ta-Yu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $1,500~ $0~